REQUIREMENT OF GAMMA-CARBOXYGLUTAMIC ACID RESIDUES FOR THE BIOLOGICAL-ACTIVITY OF GAS6 - CONTRIBUTION OF ENDOGENOUS GAS6 TO THE PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS
T. Nakano et al., REQUIREMENT OF GAMMA-CARBOXYGLUTAMIC ACID RESIDUES FOR THE BIOLOGICAL-ACTIVITY OF GAS6 - CONTRIBUTION OF ENDOGENOUS GAS6 TO THE PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS, Biochemical journal, 323, 1997, pp. 387-392
Gas6 (encoded by growth-arrest-specific gene 6) is a gamma-carboxy-glu
tamic acid (Gla)-containing protein which is released from growth-arre
sted vascular smooth muscle cells (VSMCs) and potentiates VSMC prolife
ration induced by Ca2+-mobilizing growth factors, but not that induced
by receptor tyrosine kinases. In this study we examined the importanc
e of Gla residues for the biological activities of Gas6 and tried to a
ssess the importance of endogenous Gas6 in VSMC proliferation. We demo
nstrated that Gla-deficient Gas6 lacked receptor-binding and growth-po
tentiating activities. Therefore the vitamin K-dependent modification
of Gas6 appeared to be essential for its biological activities. Next w
e used warfarin, an inhibitor of vitamin K-dependent gamma-carboxylati
on, to estimate the contribution of endogenous Gas6 to VSMC proliferat
ion. Warfarin markedly inhibited the thrombin-induced proliferation of
VSMC without affecting the mRNA or protein expression of Gas6. Theref
ore the inhibition seems to be due to prevention of the vitamin K-depe
ndent modification of Gas6. However, warfarin did not affect epidermal
growth factor-induced proliferation. A neutralizing antibody against
Gas6 gave a similar result, i.e. it inhibited thrombin-induced VSMC pr
oliferation but not that induced by epidermal growth factor. These res
ults indicate that endogenously produced Gas6 is very important for VS
MC proliferation induced by Ca2+-mobilizing growth factors dependent g
amma-carboxylation, to estimate the contribution of endogenous Gas6 to
VSMC proliferation. Warfarin markedly inhibited the thrombin-induced
proliferation of VSMC without affecting the mRNA or protein expression
of Gas6. Therefore the inhibition seems to be due to prevention of th
e vitamin K-dependent modification of Gas6. However, warfarin did not
affect epidermal growth factor-induced proliferation. A neutralizing a
ntibody against Gas6 gave a similar result, i.e. it inhibited thrombin
-induced VSMC proliferation but not that induced by epidermal growth f
actor. These results indicate that endogenously produced Gas6 is very
important for VSMC proliferation induced by Ca2+-mobilizing growth fac
tors.